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1. Introduction 
Oxidation of ethanol in the liver leads to the 
formation of acetaldehyde which is potentially more 
toxic than ethanol [l] . Korsten et al. [2] have 
demonstrated that following administration of 
ethanol, blood acetaldehyde concentrations are 
elevated to a greater extent in alcoholics (42.7 
nmol/ml) than in non-alcoholics (26.5 nmol/ml) 
which suggests that in alcoholics either the rate of 
formation or of catabolism of acetaldehyde is altered 
Thus, acetaldehyde seems to be implicated in 
alcoholism-related disorders (Korsten et al. and 
Raskin [2]). 
This paper is the first report of occurrence of 
aldehyde dehydrogenase (EC 1.2.1.3) in blood. In 
the rat high aldehyde dehydrogenase levels in organs 
other than liver have been found [3] ; no aldehyde 
dehydrogenase activity was, however, detected in the 
blood. The disappearance of acetaldehyde upon 
incubation with rat blood has been attributed to 
irreversible binding of acetaldehyde to hemoglobin 
[4]. Recently, two aldehyde dehydrogenases differ- 
ing greatly in kinetic properties were isolated here 
from human liver [5] . Using human liver enzymes as 
markers, samples of blood (the only readily available 
human tissue) from a number of individuals with no 
known alcoholic history were examined. The results 
demonstrating and identifying aldehyde dehydro- 
genases in human blood are presented in this paper. 
2. Materials and methods 
Blood was collected and fractionated into plasma, 
membranes and intracellular fluid as described by 
ElsevierlNorth-Holland Biomedical Press 
Hanahan and Ekholm [6] except that EDTA treated 
(not heparinized) vacutainer tubes were used and 
1 mM EDTA plus 0.1% 2-mercaptoethanol were 
incorporated into all buffers to stabilize aldehyde 
dehydrogenase. Membranes were dissolved by over- 
night incubation at 4’C in 0.26% w/v sodium 
deoxycholate also containing 1 mM EDTA and 0.1% 
2-mercaptoethanol. An attempt was made to deter- 
mine aldehyde dehydrogenase activity in 0.09 M pyro- 
phosphate buffer pH 9.0 containing 450 PM NAD 
and 13.5 mM propionaldehyde in cuvettes of 1 -cm 
light path and 3-ml volume. The reaction was started 
by addition of enzyme and followed at 340 nm and 
25°C on a Varian 635 double beam recording spectro- 
photometer at 1: 10 expanded scale. The control 
contained all components of the assay except 
propionaldehyde. Another control contained all 
components except the blood extract. The net rate 
of oxidation of propionaldehyde was obtained after 
subtraction of values obtained with both controls. In 
all blood fractions from 14 human subjects the iso- 
enzyme content was simultaneously examined by 
electrophoresis. Kinetic measurements were made at 
varying concentrations of propionaldehyde with a 
Cary 118 Spectrophotometer at 1:50 scale expansion, 
using blood aldehyde dehydrogenase partially purified 
on DEAE Sephadex. 
For electrophoresis 5-ml aliquots of blood fractions 
were concentrated by vacuum dialysis to less than 
0.5 ml against Tris-HCl buffer, pH 7.6, containing 
EDTA and 2-mercaptoethanol. The dissolved mem- 
brane fractions were concentrated against sodium 
deoxycholate. Electrophoresis was done on starch gel 
in pH 5.5 citrate buffer (10 mM in the gel and 50 mM 
in the tank) at 200 V overnight at 4°C. The gels were 
developed in: 25 ml of 0.1 M pyrophosphate buffer 
89 
Volume 92, number 1 FCBS LETTERS August 1978 
pH 8.3 containing 1.5 mg of NAD, 10 mg nitro-blue 
tetrazolium, 1 mg phenazine methosulphate and 
13.5 mM propionaldehyde. The gels were developed 
by incubation at room temperature in the dark. 
Control gels were developed in the absence of 
substrate. 
Protein was determined by the Lowry procedure 
[7] employing bovine serum albumin (fraction V. 
Sigma Chemical Co. St. Louis, MO) as a primary 
standard. 
3. Results and discussion 
An attempt was made to assay catalytic activity of 
blood aldehyde dehydrogenase in various blood 
fractions by employing a conventional NAD reduc- 
tion method by measuring absorption at 340 nm. 
The net rate of propionaldehyde oxidation was 
variable (some values were positive, most were zero 
and some were even negative) and unrelated to 
aldehyde dehyrogenase content as simultaneously 
visualized on starch gels. Nevertheless using starch gel 
electrophoresis the presence of aldehyde dehydrogenase 
within the intracellular fluid was invariably detected. 
It is impossible at this stage to tell whether the enzyme 
also occurs in the plasma and membrane fractions. 
On one gel presence of an aldehyde dehydrogenase 
component in the membrane fraction was observed. 
this however might be a result of a contamination 
with the intracellular fraction. The plasma fraction 
contains a large amount of protein and is thus diffi- 
cult to concentrate further for vlsualisation of the 
enzyme on gels. It is therefore not excluded that 
aldehyde dehydrogenase occurs in the plasma in 
small concentrations. Our current results indicate 
that aldehyde dehydrogenase occurs in the blood 
mainly in the intracellular fraction. The distribution 
of the enzyme within various blood cells is unknown. 
The difficulty to observe NADH formation in the 
presence of crude blood fractions may account for 
the reason why aldehyde dehydrogenase was never 
previously detected in blood. 
A typical result obtained from electrophoresis of 
human blood aldehyde dehydrogenase is shown in 
fig.1. The intracellular fraction shows four aldehyde 
dehydrogenase components. The two major (E4 and 






Fig.1. Electrophoretic separation of blood aldehyde dehydro- 
genase on starch gel. (1) Liver enzyme 1 (E, ) control; (2) liver 
enzyme 2 (E, ) control; (3) intracellular fraction of human 
blood showing four aldehyde dehydrogenase components: 
E,.E,.E, andE,. 
been described previously. The two more cathodal 
components have the same mobility as the liver 
enzymes E, and E2. The aldehyde dehydrogenase 
detected by us in the membrane fraction migrated 
like the most anodal blood component. The zymo- 
grams of aldehyde dehydrogenase from the intracel- 
lular fraction of blood obtained from 14 volunteers 
were similar. 
The two anodal enzymes (E4 and Es in fig.1) 
were isolated by chromatography on DEAE 
Sephadex. The Km value for the mixture of E4 and 
E, (roughly 1: 1 mixture by visual estimation on 
starch gel) at pH 9.0 with propionaldehyde was ca. 
0.6 PM. 
The total aldehyde dehydrogenase content in the 
eels from 20 ml of blood was estimated after isolating 
the enzyme by chromatography on DEAE Sephadex 
by employing NAD (450 ,uM), propionaldehyde 
(1.35 mM). or acetaldehyde (0.68 mM) in pyrophos- 
phate buffer pH 9.0. The enzyme isolated had a total 
catalytic activity of 0.34 ymol/min: equivalent to 
17 nmol/min/ml blood. 
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The reported non-alcoholic levels of blood acetal- 
dehyde were 26.5 + 1.5 nmol/ml [2] . The value 
obtained here for blood aldehyde dehydrogenase 
activity as well as the low Km for propionaldehyde 
indicate that blood aldehyde dehydrogenase may 
play a quantitatively important role in the clearance 
of blood acetaldehyde. Higher levels of blood acetal- 
dehyde in alcoholics, among other possible reasons, 
may result from differences in the amount of blood 
aldehyde dehydrogenase or from differences in its 
isoenzyme composition. Easy accessibility of blood 
for experimental purposes will help in the study of 
this problem. The development of an assay system 
capable of determining the enzyme content in the 
presence of interfering blood components is essential. 
Since blood aldehyde dehydrogenase activity is 
high relative to the reported steady state acetaldehyde 
levels [2] , the enzyme may seriously interfere with 
acetaldehyde determination. Blood for determination 
of acetaldehyde must therefore be collected with 
suitable precautions. 
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